No Data
No Data
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Brookdale Senior Living (BKD) and Vertex Pharmaceuticals (VRTX)
Express News | Vertex Pharmaceuticals Inc : RBC Raises Target Price to $437 From $425
Cathie Wood's ARK Sheds Robinhood Stock, Adds to Amazon and Coinbase
Wells Fargo Tweaks Signature Picks List, Sells AMZN, STZ While Upping MSFT
Cantor Fitzgerald Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $480
Leerink Partners Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $600